Envista (NYSE:NVST - Get Free Report) is projected to post its Q1 2025 quarterly earnings results after the market closes on Thursday, May 1st. Analysts expect Envista to post earnings of $0.21 per share and revenue of $608.17 million for the quarter. Envista has set its FY 2025 guidance at 0.950-1.050 EPS.
Envista (NYSE:NVST - Get Free Report) last issued its quarterly earnings results on Wednesday, February 5th. The company reported $0.24 earnings per share for the quarter, topping the consensus estimate of $0.23 by $0.01. Envista had a positive return on equity of 3.86% and a negative net margin of 44.56%. On average, analysts expect Envista to post $1 EPS for the current fiscal year and $1 EPS for the next fiscal year.
Envista Stock Down 0.0 %
Shares of NVST stock traded down $0.00 during mid-day trading on Tuesday, reaching $15.96. 201,324 shares of the company's stock traded hands, compared to its average volume of 2,499,468. The company has a quick ratio of 1.76, a current ratio of 2.04 and a debt-to-equity ratio of 0.44. The company's 50-day moving average price is $17.10 and its 200-day moving average price is $19.10. The company has a market cap of $2.70 billion, a P/E ratio of -2.45, a P/E/G ratio of 1.27 and a beta of 1.12. Envista has a 12 month low of $14.22 and a 12 month high of $23.00.
Analyst Ratings Changes
NVST has been the topic of several recent research reports. Jefferies Financial Group upped their price target on Envista from $20.00 to $22.00 and gave the stock a "hold" rating in a research note on Thursday, January 23rd. Wells Fargo & Company set a $19.00 price target on Envista in a research report on Saturday, March 8th. New Street Research set a $19.00 price objective on shares of Envista in a research report on Thursday, March 6th. Needham & Company LLC reaffirmed a "hold" rating on shares of Envista in a report on Thursday, March 6th. Finally, Morgan Stanley set a $16.00 price target on shares of Envista in a report on Tuesday, April 15th. Two equities research analysts have rated the stock with a sell rating, ten have issued a hold rating and three have given a buy rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of "Hold" and a consensus target price of $19.96.
Read Our Latest Stock Analysis on Envista
About Envista
(
Get Free Report)
Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products.
Further Reading
Before you consider Envista, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Envista wasn't on the list.
While Envista currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
